| GA20281-1mg |
|
121250-95-1 |
(Propionyl¹,D-Tyr(Et)²,Val⁴,Abu⁶,Arg⁸·⁹)-Vasopressin
|
0 |
C53H82N16O11 |
|
|
|
| GA20280-1mg |
|
179986-93-7 |
(Pro³⁴)-Peptide YY (human)
|
0 |
C194H294N54O56 |
|
|
|
| GA20280-005mg |
|
179986-93-7 |
(Pro³⁴)-Peptide YY (human)
|
0 |
C194H294N54O56 |
|
|
|
| GA20279-5mg |
|
161650-01-7 |
(Pro³⁰,Tyr³²,Leu³⁴)-Neuropeptide Y (28-36)
|
0 |
C57H91N17O12 |
|
|
|
| GA20279-1mg |
|
161650-01-7 |
(Pro³⁰,Tyr³²,Leu³⁴)-Neuropeptide Y (28-36)
|
0 |
C57H91N17O12 |
|
|
|
| GA20278-1mg |
|
299898-52-5 |
(Pro³)-Gastric Inhibitory Polypeptide (human)
|
0 |
C226H338N60O64S |
|
|
|
| GA20278-005mg |
|
299898-52-5 |
(Pro³)-Gastric Inhibitory Polypeptide (human)
|
0 |
C226H338N60O64S |
|
|
|
| GA20277-25mg |
|
159600-82-5 |
(p-Iodo-Phe⁷)-ACTH (4-10)
|
0 |
C44H58IN13O10S |
|
|
|
| GA20277-5mg |
|
159600-82-5 |
(p-Iodo-Phe⁷)-ACTH (4-10)
|
0 |
C44H58IN13O10S |
|
|
|
| GA20276-5mg |
|
135447-36-8 |
(Phenylac¹,D-Tyr(Me)²,Arg⁶·⁸,Tyr-NH₂⁹)-Vasopressin
|
0 |
C62H83N17O13 |
|
|
|
| GA20276-1mg |
|
135447-36-8 |
(Phenylac¹,D-Tyr(Me)²,Arg⁶·⁸,Tyr-NH₂⁹)-Vasopressin
|
0 |
C62H83N17O13 |
|
|
|
| GA20275-5mg |
|
148565-73-5 |
(Phenylac¹,D-Tyr(Me)²,Arg⁶·⁸,Lys-NH₂⁹)-Vasopressin
|
0 |
C59H86N18O12 |
|
|
|
| GA20275-1mg |
|
148565-73-5 |
(Phenylac¹,D-Tyr(Me)²,Arg⁶·⁸,Lys-NH₂⁹)-Vasopressin
|
0 |
C59H86N18O12 |
|
|
|
| GA20274-5mg |
|
129520-65-6 |
(Phenylac¹,D-Tyr(Et)²,Lys⁶,Arg⁸,des-Gly⁹)-Vasopressin
|
0 |
C54H76N14O11 |
|
|
|
| GA20274-1mg |
|
129520-65-6 |
(Phenylac¹,D-Tyr(Et)²,Lys⁶,Arg⁸,des-Gly⁹)-Vasopressin
|
0 |
C54H76N14O11 |
|
|
|
| GA20273-25mg |
|
118476-87-2 |
(Phe⁴)-Dermorphin (1-4) amide
|
0 |
C30H35N5O5 |
|
|
|
| GA20273-5mg |
|
118476-87-2 |
(Phe⁴)-Dermorphin (1-4) amide
|
0 |
C30H35N5O5 |
|
|
|
| GA20272-25mg |
|
2480-41-3 |
|
0 |
C42H65N13O11S2 |
|
|
|
| GA20272-5mg |
|
2480-41-3 |
|
0 |
C42H65N13O11S2 |
|
|
|
| GA20271-1mg |
|
97773-00-7 |
(Phe²,Nle⁴)-ACTH (1-24) (human, bovine, rat)
|
0 |
C137H212N40O30 |
|
|
|
